Illumigyn

Jerusalem, Israel Founded: 2014 • Age: 12 yrs
Colonoscope for cervical cancer detection procedures is developed.

About Illumigyn

Illumigyn is a company based in Jerusalem (Israel) founded in 2014.. Illumigyn has raised $38 million across 2 funding rounds from investors including Ubicom Holdings and Yozma. Illumigyn operates in a competitive market with competitors including Guided Therapeutics, MobileODT, Mobidiag, Periwinkle Technologies and Zilico, among others.

  • Headquarter Jerusalem, Israel
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $38 M (USD)

    in 2 rounds

  • Latest Funding Round
    $33 M (USD), Series B

    Nov 03, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Illumigyn
Headcount 10-50
Employee Profiles 8
Board Members and Advisors 12
Employee Profiles
People
Orr Zion
COO
People
Moshe Shtengel
CEO
People
Bosmat Keinan
Administrative Manager
People
Yam Salman
VP Global Sales & Business Development

Unlock access to complete

Board Members and Advisors
people
Lior Greenstein
Board Member
people
Mark Spitzer
Scientific Advisor
people
Rami Bali
Scientific Advisor
people
Robert K. Zurawin
Scientific Advisor

Unlock access to complete

Funding Insights of Illumigyn

Illumigyn has successfully raised a total of $38M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $33 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $33.0M
  • First Round

    (21 Nov 2016)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2021 Amount Series B - Illumigyn Valuation

investors

Nov, 2016 Amount Series A - Illumigyn Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Illumigyn

Illumigyn has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ubicom Holdings and Yozma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Provider of IT service suite solutions
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Illumigyn

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Illumigyn

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Illumigyn Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Illumigyn

Illumigyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guided Therapeutics, MobileODT, Mobidiag, Periwinkle Technologies and Zilico, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Light-based devices for cervical cancer diagnostics are developed.
domain founded_year HQ Location
Smartphone-based tools for cervical cancer screening are developed.
domain founded_year HQ Location
In vitro diagnostics for infectious diseases are developed and provided.
domain founded_year HQ Location
Developer of device for detecting cervical abnormalities
domain founded_year HQ Location
Real-time cancer diagnostics via Electrical Impedance Spectroscopy are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Illumigyn

When was Illumigyn founded?

Illumigyn was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Illumigyn located?

Illumigyn is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.

Is Illumigyn a funded company?

Illumigyn is a funded company, having raised a total of $38M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Nov 21, 2016.

What does Illumigyn do?

Illumigyn was founded in 2014 in Jerusalem, Israel, within the medical device sector. Focus is placed on developing the Gynescope, a patented imaging colposcope equipped with multispectral illumination for early cervical cancer detection. Operations involve enabling imaging during simultaneous interventional procedures to facilitate clinical outcomes. The device is designed for use in womens health diagnostics and related interventions.

Who are the top competitors of Illumigyn?

Illumigyn's top competitors include Periwinkle Technologies, Guided Therapeutics and Mobidiag.

Who are Illumigyn's investors?

Illumigyn has 2 investors. Key investors include Ubicom Holdings, and Yozma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available